chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received vaccine after published expiration date. Moderna Company analyzed lot 007B21A and advised vaccine maintained activity required to protect against covid on date vaccine was administered. Also patient did not call in to complain of side effects.
Asthma exacerbation after both the 1st and 2nd vaccines of Pfizer COVID-19.
Information has been received from a nurse referring to multiple, unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with doses of improperly stored VARIVAX (Merck) (lot# L001325 with expiration date of 13-JAN-2017, lot# K011797 with expiration date of 21-AUG-2016, dose, strength and route unknown). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a nurse practitioner refers to a 30 year old male patient (not from this country otherwise healthy) with an unknown immunization status, no pertinent medical history and no drug reaction/allergies. On 10-APR-2013 the patient was vaccinated with a dose of M-M-R II (lot # H012572, exp. 29-JUN-2014) 0.5 ml, subcutaneously. There was no concomitant medication. On 19-APR-2013, the patient developed swollen glands, specifically parotid and postauricular, and lymphadenopathy. Nurse stated the patient presently felt well and his vitals were fine, no rash, no fever but concerned about mumps. The outcome of the events was unknown. The patient contacted nurse practitioner and visited office for medical attention. No treatment was given for the event and no lab diagnostics studies were performed. Additional information has been requested.
Patient is on chronic anticoagulation therapy for atrial fibrilation no active bleeding noted when patient left the clinic however had slow subcutaneous bleeding that eventually extended distally from injection site to elbow and also extended medially and laterally for this length.  Patient had some soreness with this but no redness warmth or swelling.  Ended up basically with a very large hematoma.
Information has been received from a registered nurse who stated that on 26-DEC-2007 she was inadvertently vaccinated SC with a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck). She was administered the vaccine at a "walk in clinic". No adverse experience was related to this event. No further information was available. There was no product quality complaint.  Further information has been received from the nurse who reported that the patient was vaccinated with VARIVAX (LOT # 654590/1324U) on 24-DEC-2007 at 2:19 PM in the left deltoid.  The nurse reported that t he medical assistant took the wrong med instead of ZOSTAVAX (Merck) from the freezer.  The medical assistant realized the mistake and the patient was called back to the office.  It was reported that the patient had recovered on 26-DEC-2007.  Additional information has been requested.
The patient received the 2nd Shingrix vaccination on 05/07/23. The next day the patient had pain and swelling at the injection site and he thought it was a normal reaction to the vaccination. It continued to progress in redness, swelling and pain till on 5/10/23 it began to radiate to the lower arm and shoulder and he went to the urgent care and was diagnosed with Cellulitis. He was prescribed Bactrim antibiotics, which he picked up on 5/10/23.
Patient was here to receive a flu shot and an error was made.  She received the new Comirnaty from Pfizer instead.  She has not had an actual adverse reaction but we were told by our corporate office to report to the VAERS system.
Four hours after vaccine he started getting severe pains in left shoulder joint.  Unable to move arm.
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications information provided.  No treatment medication information reported.
no adverse effect reported; INADVERTENT administration to adult female patient; INADVERTENT administration to adult female patient; This spontaneous report was received from a physician and refers to an adult female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 03-NOV-2020, the patient was inadvertently administered a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (dose, route of administration, lot# and expiration date were not reported). No adverse effects reported.
No adverse event; Adult patient received a 6 to 11 year old dose instead of the bivalent booster; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Adult patient received a 6 to 11 year old dose instead of the bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.   On 18-Oct-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Adult patient received a 6 to 11 year old dose instead of the bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Adult patient received a 6 to 11 year old dose instead of the bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Adult patient received a 6 to 11 year old dose instead of the bivalent booster).    No Concomitant medications were provided. It was reported that, patient had received 3 doses prior to the administration error. No treatment medications were provided.
13 hours after the injection developed  chills, myalgia, fever, rigors. Also local muscle pain at injection site. Systemic symptoms of fever (up to 101.4F), and myalgia resolved within 24 hours (about 36 hours since the injection). Also developed left axillary lymphadenopathy within 24 hours, which is improving but still some lymph node ttp present after 7 days
63 y/o female with PMH of GI issues, s/p ileostomy c/o pain (4/10) in her left shoulder and left SCM. Pt was assessed by clinical leads and a heat pack was applied to her left shoulder. Pt was re-assessed 2 minutes later to monitor symptoms. Pt appeared diaphoretic, pale, complaining of dizziness + nausea. Ice packs were applied to her neck and forehead and EMS was called to monitor vitals, lay pt on a stretcher, 2L O2 via nasal canula. Pt reported "feeling awful" and did not respond to any questions, pt maintained consciousness throughout the entire encounter. Pt was attached to a monitor and a 12 lead EKG was obtained that showed evidence of a wide QRS, new right bundle branch, prolonged QT and T wave changes. Pt denied any cardiac history or history of abnormal EKGs or similar prior experiences. She was immediately transported via EMS to the Hospital Emergency Room for further evaluation, pt gave consent for transport. Pt denied notifying / calling a family member or friend to inform them.   Denies chest pain, LOC, SOB, respiratory distress, vomiting, itchiness, erythema, swelling, HA, similar prior experiences  PMH: weak pelvic floor, IBS, imbalanced gut flora, ileostomy for unknown reason -  DENIES history of: cardiac issues, pulmonary issues, diverticulitis, cancer, autoimmune conditions (ulcerative colitis, crohns)  Surgical History: ileostomy, C-section Meds: Linzess, Motegrity, Baclofen, Liothyrozine  Vaccine was administered at 11:48 am in the left deltoid. Pt began experiencing symptoms at ~ 12:03pm.   General: A&Ox3 HEENT: NC/AT, EOMI, PERRL, airway patent, no trismus MSK: tenderness to left SCM, neurologically intact b/l, brisk capillary refill b/l, radial pulse 2+ b/l, full ROM b/l, 5+ strength b/l Skin: diaphoretic, pale  Pulmonary: clear to auscultation b/l  Vitals:  @12:09: BP: 74/52, HR: 53, SpO2: 96% RA,  @12:12 2L O2 NC @12:13: BP: 106/73, HR: 72, SpO2: 97% 2L NC @12:15: SpO2: 99% 2L NC @12:16: BGM: 118 @12:20: BP: 112/77, HR: 69, SpO2: 100% 2L NC
2-22-18 c/o of hoarseness and a tightness in throat that started on day of vaccine. Pain in throat now.
had a very high fever (108 degrees) / such a high fever; I was too weak to take a tepid bath or go down the stairs to get Tylenol; had a bad headache; This case was reported by a consumer via call center representative and described the occurrence of hyperpyrexia in a 65-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th March 2020, the patient received the 2nd dose of Shingrix. In March 2020, less than a day after receiving Shingrix, the patient experienced hyperpyrexia (serious criteria GSK medically significant), weakness and headache. On an unknown date, the outcome of the hyperpyrexia was not recovered/not resolved and the outcome of the weakness and headache were unknown.   It was unknown if the reporter considered the hyperpyrexia, weakness and headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 64 years or 65 years. The patient had a very high fever (108 degree F). The patient stated it was during the night. The patient was too weak to take a tepid bath or go down the stairs to get Tylenol. Less than a week after vaccination, the patient experienced had a bad headache which the patient stated as looks like a common side affect. The patient's body temperature was 101 degree F at the time of reporting. As per advice, the patient would call the doctor's office and let them know about the fever.
p/vax pt exp sore lt arm; swelling w/redness & heat; swelling described as golf ball size; also fever; dx infection secondary to the vax; placed on antibiotics
Next day felt like I had flu bad headache , body aches and no energy.Following day could not get out of bed till noon, massive headache and broke fever around4pm Saturday. Received vaccine on Thursday
Got my second HPV vaccine and two weeks later my thyroid was swollen. My regular doctor send me to get the thyroid scan done and blood work. Later was diagnosed with Graves disease by Endocrynology doctor.
Woke up at 5:00 a.m. and had chills, muscle aches, no fever, neck pain, headache, dizziness, weakness, couldn't eat or drink, walked to bathroom and so dizzy I almost fell down. Rose from bed again at 7:00 a.m. and needed assistance downstairs, extremely weak and entire body was achy. Asked for assistance to the nearby sofa and covered with a blanket, stayed on sofa until 5:00 p.m. Took two TYLENOL Extra Strength every 6 hours until bed time that evening. Finally able to eat at 6:00 pm but still very weak until next day.
Saturday, the night of the second shot, I got the chills all over my body, a headache, and a fever. The shivering prevented me from sleeping. The fever broke by Sunday morning but all day I was achey and tired. Then the fever came back the Sunday night. By Monday morning I was starting to feel better.
This spontaneous report as received from a 73 year old female patient with no medical history and no drug reactions/allergies. On 20-MAY-2013 the patient was vaccinated with ZOSTAVAX (subcutaneous, 1 time vaccine, lot#, dose/frequency were unspecified). No concomitant medication was taken. The consumer stated the vaccine was given in her left hip, and she had pain at the site of insertion on 21-MAY-2013. Patient did not seek medical attention. No lab diagnostics studies were performed and no treatment was given for the event. The outcome of pain at the site of insertion was unknown. Additional information has been requested.
This is a spontaneous report form a contactable physician, who reported similar events for 3 patients. This is first of three reports. A patient of unspecified age and gender received a single dose of TRUMENBA on an unspecified date. Medical history and concomitant medications were not reported. The patient experienced arm so sore that he/she could not move it. Also, the patient had dizziness and could not go to school for a day or 2 on an unspecified date. The outcome of the events was unknown.
Within 24 hrs patient began to experience memory difficulty, black-outs lasting up to 4 hrs, dry mouth. On 4/10/21  patient noted feeling achy joints and stiffness lasting only one day.  Patient continues to have dry mouth and short-term memory loss.  Patient reported episodic black-outs, confusion continues. Patient noted on evening of 4/09 and 4/10 she had "best sleep ever" with up to six (6) hours of uninterrupted sleep.   Some time (date unknown) patient awoke hearing voices from "a group of people wearing gray clothing like in the olden days, all standing and talking" added "and I was talking w/ them": one episode only.  Client has no psychosis in current diagnostic picture.  Client came into Clinic for individual therapy session today; has scheduled appointment with psychiatrist on 4/29/21.  Client soon will re-establish services with a primary care provider, local nurse practitioner.
Initial unsolicited report received from a healthcare professional on 12 August 2015. This case is linked with 16 other cases 2015SA105654, 2015SA121736, 2015SA121739, 2015SA121740, 2015SA121741, 2015SA121742, 2015SA121743, 2015SA121744, 2015SA121745, 2015SA121746, 2015SA121747, 2015SA121748, 2015SA121749, 2015SA121750, 2015SA121751, 2015SA121752, (same reporter, vaccine, lot number and different lot number). A 23-month-old male patient, whose medical history and concomitant medication were not reported, had received a dose of DAPTACEL (pediatric SDV) (Batch number: C4709AA, expiry date: 24 February 2017, route and site of administration were not reported) on 4 June 2015. On 5 June 2015, one day after vaccination, the patient had developed cellulitis. In ER visit, the patient received antibiotics as a corrective treatment. It was reported that, the patient was fine; none required medical attention or hospitalization. Laboratory investigations was not reported. On an unknown date, the patient was recovered from the event ("It was unknown if the patient recovered within a week or in two weeks"). Upon internal review, company assessed the event cellulitis as serious and important medical event. Documents held by sender: none. Follow-up information received from a physician on 14 September 2015. This case involves a 21-month-old patient who had received 0.5 ml intramuscular dose of DAPTACEL vaccine in left thigh. Vaccine was administered at private doctor's office/hospital. On unspecified date, the patient developed a knot at injection site, redness/ whole thigh was red. It was reported that the knot at injection site was used to indicate the swelling. Sender's Comments: Follow-up information received on 14-September-2015 does not change the previous medical assessment: Cellulitis is listed with DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE. Time to onset is compatible with a role of the vaccine. However, this case is poorly documented and no conclusion on the role of the vaccine can be drawn. Additional information on the site the patient developed cellulitis, complementary investigation results confirming the diagnosis of cellulitis, cleansing of the vaccine injection site, patient medical history (trauma, insect/animal bite, pathologies increasing the risk of cellulitis), as well as identification of the pathogen responsible for the event is needed to further assess this case.
On July 17, 2015, client received the MCV4 vaccine at 1146.  Client tolerated well, denied complaints, left clinic without difficulty.  Client returned to immunization clinic waiting room with mother at 1153.  Client was pale and stated she felt lightheaded.  RN had client lay down on floor, patient immediately became less pale.  No other distress noted.  Client remained conscious.  Client states the only food she had eaten was a package of peanut butter crackers on the way to the clinic.  Client remained in the clinic for 30 minutes, during which time she drank a Sprite.  Client was able to stand and walk without difficulty or feeling lightheaded prior to leaving clinic.  RN walked with client out to mom's personal vehicle at 1223.  Client was buckled in and denied complaint.  RN discussed with client's mother to get client food to eat and to seek medical attention and notify the health department of any further or worsening problems. RN called mother on July 20, 2015 at 0940 to follow up with patient.  Mother states patient is currently experiencing no problems.  She states client's arm was slightly reddened and swollen at the injection site throughout the weekend, but that the problem has resolved.  She states client was tired and rested on Friday.  Client's mother also states that she "didn't think about it at the time, but now I remember patient threw up on the nurse after she got this vaccine [MCV4] the last time."  RN advised mother that she and/or client should be sure future healthcare and immunization providers are aware of the occurrences following MCV4 vaccination.  Note made in client's profile regarding occurrence.
SORE ARM AS EXPECTED BY AFTERNOON (11/30); MUSCLE PAIN BECAME SHARPER AND THROUGHOUT MY BODY BY EVENING (9-10 HOURS AFTER SHOT).  CHILLS  AND FEVER INTO NEXT MORNING;  NAUSEA AND HEADACHE PERSISTED DURING SECOND DAY (12/1).  Today (12/2)  ALL SYMPTOMS ARE GONE. I DID NOT CONSULT A DR
Headache, Myalgia, UrticariaPruritus, NauseaVomiting, Fatigue, Pain Narrative:
pt recv vax 10OCT95 & devel baseball sized swelling, redness & pain @ inj site;pt also devel a fever;sx began 3-4 hr post vax & resolved over the next 2 days;
Daughter notinced that her mom has a fever of 99.8.  Gave Tylenol but wanted to know was it normal to have a fever after shot.
The second dose of vaccine was taken on 05/21 Friday at 8:30am. By that evening, I felt the usual symptoms of fever, body ache and chills, which continued for the next 48 hours. By Sunday, 05/23, I was feeling back to normal and in good health. The next morning, Monday, 05/24, I woke up with chest pain, a crushing pain by my heart and I went to the ER. An EKG was taken, and the cardiologist mentioned that it was abnormal and that a catheter angiogram needed to be done to check the arteries. That was followed by and ECG and a MRI and a stay at the hospital overnight. Next morning, the cardiologist told me that I have myocarditis caused by the vaccine and the inflammation is at the tip of the heart. I am currently on medication over the course of the next month, till my follow up visit with the cardiologist.
Dose 1 of Moderna Covid Vaccine.  After 3 days small, red, hard spot appeared.  After 12 days, rash is still getting larger, showing no signs of fading.  At day 12 it began to itch.  At day 10 I contacted my doctor to told me to make an appointment if not improving by day 14.  I will.   She did NOT give me the vaccine.
May 30 at 37+6 weeks pregnant with no pregnancy complications at this time: I experienced temporary vision loss in the field of view of my left eye. My vision in my left eye was obscured by a flashing, arching, lightning that I was afraid might be a sign of retinal or vitreal detachment. I returned to my house (was in a walk) within 5 minutes of the lightning appearing in my vision. I drank water and removed my contacts. The lightning disappeared gradually after about 15 minutes. I went to the ER/Labor&Delivery anyway to confirm I wasn?t having pre-eclampsia (which can cause retinal detachment). My blood pressure was fine, baby?s heart rate was fine, my eyes were checked by my OB and I was evaluated for signs of a potential stroke. There were no observable issues. I was discharged and advised to see an opthamologist. There have been no issues with my eyesight since this event, but I have so chosen to wear my glasses rather than my contacts. I do not think this event is related to the vaccine. I think it is more likely an event related to pregnancy and dehydration.
generalized malaise. Illness started a couple days after contact with known COVID + visitor at her house.
The pt experienced joint pain to the knee, fatigue and headaches. Pt was diagnosed with Lyme disease after the vaccine was administered.
Chills, muscle weakness.  Weakness resulted in fall, broke 3 ribs. This person was ambulatory and laid a tile floor in the months before this episode.
Per CRNP, patient came in to their office due to generalized rash, primarily on face, chest, and back, with just a few areas on legs.  General appearance was "hives" with just a few pustular areas.  Also experienced itching, headache, mild fever and general malaise.  They provided treatment of Acyclovir QIDx5days.  It was noted that he received menactra vaccine on 7-28-05.
Soon after receiving her injection, Patient started to state she was feeling funny. She repeatedly rubbed her chest and described "feeling funny" in her chest. I don't think she was feeling pain, but a tightness and heaviness in her chest. I didn't notice any difficulty breathing and the episode seemed to resolve within 20 minutes. She also became a bit lethargic, repeatedly closing her eyes and drifting to sleep. The intensity of the lethargy seemed to decrease after 20 minutes as well, but did persist through the rest of the day.
Patient received 3 vaccines. Immediately after, while still seated, he felt faint and passed out for less than 30 seconds. When he awoke on his own,  he had ringing in his ears, was sweaty and pale in color. Patient was provided a cold wet towel for his forehead and some water.  He sat for 20 minutes or so until he was ready to leave.
Sore arm and hugely swollen lymph nodes under arm1st then neck, and groin. Lumps appeared on 1/22/15. On 1/23/15 came home from work-node under arm bigger than fist. On 1/4 started vomiting, diarrhea, chills, SOB, fever, finally went to ER. Sat eve. at 10:00- Did breathing tx, IV, BENADRYL, steroid (Prednisone) and something for stomach. Still off work 1/26 and 1/27. O2 level still down to 91.
Patient had received the PFIZER vaccine back on 4/16/2021 and was given the JANSSEN vaccine 06/04/2021 NOT knowing he had already received the Pfizer vaccine previously
This spontaneous report as received from a physician refers to currently a 7 year old non-pregnant female child. On 01-AUG-2006 the patient was vaccinated with the first dose of RECOMBIVAX HB injection, 0.5 ml, intramuscularly (lot number and expiration date not provided). The second dose was administered on 05-SEP-2006 and the third dose was administered on 07-FEB-2007. The reported stated that on an unknown date a titer for Hepatitis B were drawn and the titer resulted negative. The outcome of Hepatitis B titer negative was unknown. No treatment was given for adverse event. This is one of 10 reports from the same source. Additional information has been requested.
11/27/07 Received VARIVAX L upper arm.  11/29/07 L upper arm, almost whole L upper arm erythematous & swollen (+) fever.  11/30/07 Admitted for L upper arm cellulitis.12/21/07-records received for DOS 11/30/07-DX DX: Cellulitis of left arm. Day after receiving vaccination, C/O pain, swelling and erythema which continued to increase. Fever 101.